IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
De scrip tion: Re searcher, de vel oper, man u fac -
turer, for mu la tor, packager/as sem bler, im porter,
ex porter, pro moter, sales/detailer. De vel ops,
man u fac tures, ex ports, sells/de tails for other
com pa nies. Prod uct ranges in clude: phar ma ceu ti -
cal prod ucts (branded, unbranded, pre scrip tion),
hos pi tal pharmaceuticals, in ter me di ates, bio tech -
nol ogy prod ucts, vet er i nary pharmaceuticals.
Established 1946.
Con tacts (Pharm): Chair man: Chris tian
Seiwald; Com mer cial Op er a tions: Werner
Messner; Man u fac ture: Dr Hein rich Scherfler
Par ent of: Hexal, Aus tria; Lek, Lat via.
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 70-75 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
CEFTRIAXON-SANDOZ (cephalosporin)
CLAVAMOX (pen i cil lin broad spec trum)
FOSFOMYCIN-SANDOZ (an ti bac te rial other)
CIPROFLOXACIN-SDZ (fluoroquinolone)
OSPEN (pen i cil lin me dium/nar row spec trum)
Ther a peu tic Range:
antibacterials sys temic 65%
renin-an gio ten sin sys tem agents 7%
thy roid ther a pies 6%
ant ac ids/antiflatulents/antiulcerants 5%
lipid-reg u lat ing/antiatheroma prep a ra tions 4%
Lead ing Dose Forms:
coated tab lets 29%
in fu sions 21%
vi als 20%
tab lets 16%
liq uids 6%
BANGLADESH
NOVARTIS
Full Name: Novartis (Ban gla desh) Ltd
Postal Ad dress: PO Box 431, Dhaka 1000
Street Ad dress: House 50, Road 2A, Dhanmondi
R.A., Dhaka 1209
Tel: +880 2 8615302
Fax: +880 2 8613489
Email: novartis.bd@novartis.com
De scrip tion: Man u fac turer, im porter, ex porter,
dis trib u tor, pro moter, sales/detailer. Prod uct
ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion), di etetic/nu tri tional prod -
ucts, oph thal mic prod ucts, vet er i nary
pharmaceuticals. Es tab lished 1997. 588 phar ma -
ceu ti cal em ploy ees in 2005. Di vi sions in clude:
Sandoz. Pharma; Sandoz; OTC & MN; Animal
Health; Ophthalmics.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 280 (2005)
Con tacts (Pharm): Chair man:
Ashfaque-ur-Rahman; Com mer cial Op er a tions:
M.M. Alam; Man u fac ture: Murshi Siraj Uddin;
Mar ket Re search: S.A.A. Saher; Gen eral Con tact:
M.M. Alam
Sub sid iary of: Novartis, Swit zer land (60%)
(group: Novartis, Swit zer land); Ban gla desh
Chem i cal In dus tries, Ban gla desh (40%)
Phar ma ceu ti cal Sales: US$ 5-6 mil lion
Prod ucts (% of Sales by Lead ing 5): 70-75%
Ther a peu tic Classes (% of Sales by Lead ing
5): 80-85%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
VOLTALIN (antirheumatic non-steroidal)
TEGRETOL (antiepileptic)
DIOVAN (an gio ten sin-II an tag o nist plain)
EXELON (anti-Alz hei mer prod uct)
LESCOL (cho les terol/triglyceride reg u lat ing prep -
a ra tion)
Ther a peu tic Range:
anti rheu ma tics sys temic 41%
antiepileptics 18%
renin-an gio ten sin sys tem agents 9%
psychoanaleptics 8%
CNS drugs other 5%
Lead ing Dose Forms:
tab lets 44%
sup pos i to ries 18%
coated tab lets 17%
cap sules 11%
am poules 7%
BELARUS
NOVARTIS
Postal Ad dress: 103104 Mos cow, Mos cow Rep -
re sen ta tive Of fice, 15 B Palashevskiy Pereulok,
Rus sia
© 2009 IMS Health In cor po rated or its af fil i ates Page 152